Roberto Camerini is Director at SCICLONE PHARMACEUTICALS INC (SCLN). They have made 1 open-market trade across 1 company since 2011, most recently 2011-06-14.
CIK 0001460684
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SCLN | 14,710 | $164K |
Shares reported on the most recent Form 4, priced at the 2011-06-16 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SCLN | SELL | 2011-06-14 | 2011-06-16 | $4.97 | $340K | -15.6% | -3.7% | -3.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.